Equities analysts predict that ACM Research, Inc. (NASDAQ:ACMR – Get Rating) will announce sales of $82.10 million for the current fiscal quarter, according to Zacks. Four analysts have provided estimates for ACM Research’s earnings, with the lowest sales estimate coming in at $72.00 million and the highest estimate coming in at $106.60 million. ACM Research posted sales of $53.86 million during the same quarter last year, which would indicate a positive year-over-year growth rate of 52.4%. The company is expected to announce its next quarterly earnings results on Monday, January 1st.
According to Zacks, analysts expect that ACM Research will report full year sales of $379.46 million for the current financial year, with estimates ranging from $370.00 million to $385.00 million. For the next financial year, analysts expect that the company will post sales of $498.42 million, with estimates ranging from $470.00 million to $540.00 million. Zacks’ sales calculations are a mean average based on a survey of research analysts that cover ACM Research.
ACM Research (NASDAQ:ACMR – Get Rating) last posted its quarterly earnings data on Friday, May 6th. The specialty retailer reported ($0.01) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.11) by $0.10. The business had revenue of $42.20 million during the quarter, compared to the consensus estimate of $49.25 million. ACM Research had a net margin of 10.26% and a return on equity of 5.49%. ACM Research’s quarterly revenue was down 3.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.10 EPS.
NASDAQ ACMR opened at $13.65 on Monday. The company has a current ratio of 3.70, a quick ratio of 3.57 and a debt-to-equity ratio of 0.03. The company has a fifty day simple moving average of $18.15 and a 200 day simple moving average of $24.69. The company has a market cap of $738.12 million, a P/E ratio of 34.41 and a beta of 0.77. ACM Research has a 1 year low of $11.23 and a 1 year high of $39.71.
In other news, insider Mark Mckechnie sold 5,000 shares of the company’s stock in a transaction dated Thursday, March 10th. The shares were sold at an average price of $64.20, for a total value of $321,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Haiping Dun sold 12,269 shares of the company’s stock in a transaction dated Wednesday, March 9th. The stock was sold at an average price of $82.09, for a total transaction of $1,007,162.21. The disclosure for this sale can be found here. 46.02% of the stock is currently owned by corporate insiders.
A number of large investors have recently modified their holdings of ACMR. Advisor Group Holdings Inc. grew its holdings in ACM Research by 166.4% during the 1st quarter. Advisor Group Holdings Inc. now owns 1,500 shares of the specialty retailer’s stock worth $31,000 after acquiring an additional 937 shares during the last quarter. Great West Life Assurance Co. Can boosted its stake in shares of ACM Research by 210.6% in the 1st quarter. Great West Life Assurance Co. Can now owns 1,752 shares of the specialty retailer’s stock valued at $39,000 after purchasing an additional 1,188 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of ACM Research by 200.0% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 4,530 shares of the specialty retailer’s stock valued at $94,000 after purchasing an additional 3,020 shares during the last quarter. Citigroup Inc. boosted its stake in shares of ACM Research by 69.9% in the 1st quarter. Citigroup Inc. now owns 7,203 shares of the specialty retailer’s stock valued at $149,000 after purchasing an additional 2,963 shares during the last quarter. Finally, Maverick Capital Ltd. boosted its stake in shares of ACM Research by 21.8% in the 3rd quarter. Maverick Capital Ltd. now owns 1,421 shares of the specialty retailer’s stock valued at $156,000 after purchasing an additional 254 shares during the last quarter. 19.88% of the stock is currently owned by hedge funds and other institutional investors.
About ACM Research (Get Rating)
ACM Research, Inc, together with its subsidiaries, develops, manufactures, and sells single-wafer wet cleaning equipment for enhancing the manufacturing process and yield for integrated chips worldwide. It offers space alternated phase shift technology for flat and patterned wafer surfaces, which employs alternating phases of megasonic waves to deliver megasonic energy in a uniform manner on a microscopic level; timely energized bubble oscillation technology for patterned wafer surfaces at advanced process nodes, which provides cleaning for 2D and 3D patterned wafers; Tahoe technology for delivering cleaning performance using less sulfuric acid and hydrogen peroxide; and electro-chemical plating technology for advanced metal plating.
- Get a free copy of the StockNews.com research report on ACM Research (ACMR)
- Cloudflare Inc: Struggling but With Great Opportunities
- Why Investors Suddenly Love These 2 Software Stocks
- Volatile Times Are When AbbVie Shines the Brightest
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for ACM Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ACM Research and related companies with MarketBeat.com's FREE daily email newsletter.